The future of GLP-1RAs in anti-inflammatory therapy looks promising, with ongoing research aiming to optimize their therapeutic use, develop patient-specific treatment paradigms, and explore novel applications
These compounds bind to receptors and trigger defined responses within the body
No one size fits all plans
Testing may include purity verification, LCMS screening, heavy metals analysis, endotoxin analysis, and sterility testing
Randomized controlled trials before the issue of CVOTs by the FDA in 2008 mainly focused on the efficacy of the blood glucose-lowering effects and a broad spectrum of adverse effects, with limited numbers of cardiovascular adverse events and relatively short follow-up duration
The dysregulation of the hypothalamicpituitaryadrenal axis in diet-induced prediabetic male Sprague Dawley rats